Bio Protocol vs Velo — how do they compare? Bio Protocol trades at Rp436.48 (market cap Rp997,43M, Rp162,4M 24h volume), while Velo trades at Rp56.97 (market cap Rp1T, Rp29,92M 24h volume). The key difference: Velo is far larger — about 1002.6× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 17,6B / 24B VELO (74%) for Velo. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Velo for 28 Days on average.
| BIO | VELO | |
|---|---|---|
Market Cap | Rp997,43M | Rp1T |
Volume (24h) | Rp162,4M | Rp29,92M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 17,6B / 24B VELO (74%) |
Typical Hold Time | 18 Days | 28 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
VELO is trading at Rp57.28 with a market cap of Rp1.01 trillion, showing a bearish technical signal from moving averages while oscillators remain neutral. The token faces immediate support at Rp55 and resistance at Rp59. Recent ecosystem activity includes protocol upgrades and increased network adoption, though trading volume remains moderate. The circulating supply is 17.6 million VELO out of a max 24 million, with a 74% circulation rate.
Overall outlook is cautious due to bearish technicals and neutral sentiment. Key opportunities lie in potential breakout above Rp59 resistance, while risks include high volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity closely.
What Pluang investors did over the last 30 days
Latest headlines on both assets
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Velo Labs is building a unique federated credit exchange network. This network is powered by the Velo Protocol, which is a blockchain financial protocol enabling digital credit issuance and borderless asset transfers for businesses using a smart contract system. The project's core mission is to enable partners to safely and securely transfer value between each other in a timely and transparent way.
Read more on VELO →